These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6619561)

  • 1. Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus.
    Gammon WR; Briggaman RA; Inman AO; Merritt CC; Wheeler CE
    J Invest Dermatol; 1983 Oct; 81(4):320-5. PubMed ID: 6619561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-activating immune deposits in systemic lupus erythematosus skin.
    Gammon WR; Merritt CC; Henke DC; Robinson T; Henley N; DeAngelo L
    J Invest Dermatol; 1983 Jul; 81(1):14-20. PubMed ID: 6345682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood-onset bullous systemic lupus erythematosus.
    Lourenço DM; Gomes RC; Aikawa NE; Campos LM; Romiti R; Silva CA
    Lupus; 2014 Nov; 23(13):1422-5. PubMed ID: 25074872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous systemic lupus erythematosus.
    Olansky AJ; Briggaman RA; Gammon WR; Kelly TF; Sams WM
    J Am Acad Dermatol; 1982 Oct; 7(4):511-20. PubMed ID: 6754773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three cases of bullous lupus erythematosus].
    Jira M; Elqatni M; Sekkach Y; Elomri N; Mekouar F; Ghafir D
    Ann Dermatol Venereol; 2013 Dec; 140(12):778-83. PubMed ID: 24315223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Carlo JR; Wheeler CE
    J Invest Dermatol; 1982 Apr; 78(4):285-90. PubMed ID: 7040558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence.
    Gammon WR; Robinson T; Briggaman RA; Wheeler CE
    J Invest Dermatol; 1982 Nov; 79(5):312-7. PubMed ID: 6752293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases.
    de Risi-Pugliese T; Cohen Aubart F; Haroche J; Moguelet P; Grootenboer-Mignot S; Mathian A; Ingen-Housz-Oro S; Hie M; Wendremaire N; Aucouturier F; Lepelletier F; Miyara M; Bader-Meunier B; Rémy P; Fabien N; Francès C; Barete S; Amoura Z
    Semin Arthritis Rheum; 2018 Aug; 48(1):83-89. PubMed ID: 29191376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular immune reactants in patients dying with systemic lupus erythematosus.
    Karpik AG; Schwartz MM; Dickey LE; Streeten BW; Roberts JL
    Clin Immunol Immunopathol; 1985 Jun; 35(3):295-312. PubMed ID: 3886222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen.
    Barton DD; Fine JD; Gammon WR; Sams WM
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 2):369-73. PubMed ID: 3525621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous disease in systemic lupus erythematosus.
    Rappersberger K; Tschachler E; Tani M; Wolff K
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):745-52. PubMed ID: 2681283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.
    Provost TT; Tomasi TB
    J Clin Invest; 1973 Jul; 52(7):1779-87. PubMed ID: 4352464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus.
    Bidani AK; Roberts JL; Schwartz MM; Lewis EJ
    Am J Med; 1980 Dec; 69(6):849-58. PubMed ID: 7004181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G; Lavin L; Ziskind M; Koffler D
    N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous bullae following acute steroid withdrawal in systemic lupus erythematosus.
    Callen JP
    Br J Dermatol; 1981 Nov; 105(5):603-6. PubMed ID: 7295576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus with vesiculobullous lesions. Immunoelectron microscopic studies.
    Tani M; Shimizu R; Ban M; Murata Y; Tamaki A
    Arch Dermatol; 1984 Nov; 120(11):1497-501. PubMed ID: 6388508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of anti-basement membrane zone antibodies in bullous systemic lupus erythematosus.
    Janniger CK; Kowalewski C; Mahmood T; Lambert WC; Schwartz RA
    J Am Acad Dermatol; 1991 Apr; 24(4):643-7. PubMed ID: 2033145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.